Matrix Metalloproteinase9 as the Protein Target in Anti-Breast Cancer Drug Discovery: An Approach by Targeting Hemopexin Domain

Future Journal of Pharmaceutical Sciences
doi 10.1186/s43094-019-0001-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Nervous System: An Ideal Therapeutic Target for Anti-Schistosomal Drug Discovery

Tropical Medicine & Surgery
2013English

A FRET-based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anti-Cancer Drug Target

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2020English

mTOR Mediated Anti-Cancer Drug Discovery

Drug Discovery Today: Therapeutic Strategies
2009English

Hot-Spot Analysis for Drug Discovery Targeting Protein-Protein Interactions

Expert Opinion on Drug Discovery
Drug Discovery
2018English

Mammaglobin as a Potential Molecular Target for Breast Cancer Drug Delivery

Cancer Cell International
Cancer ResearchOncologyGenetics
2009English

Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach

English

The Discovery of Purine-Based Agents Targeting Triple-Negative Breast Cancer and the αB-crystallin/VEGF Protein–protein Interaction

Medicinal Chemistry Research
Organic ChemistryToxicologyPharmaceuticsPharmacology
2018English

Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents That Target the Interaction With Dbf4 by the Fragment Complementation and Drug Repositioning Approach

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

‘Big Data’ Approaches for Novel Anti-Cancer Drug Discovery

Expert Opinion on Drug Discovery
Drug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy